Oncopeptides is a clinical development pharmaceutical company. It develops anti-cancer drugs. The Company has created Ygalo, a cytotoxic therapy that is in late-stage development use for the treatment of multiple myeloma.
Market capitalization (19-Nov-2020)
Closing stock price (19-Nov-2020)
When was Oncopeptides founded?
Oncopeptides was founded in 2000.
Who are Oncopeptides key executives?
Oncopeptides's key executives are Brian Stuglik, Cecilia Daun Wennborg and Anders Martin-Löf.
How many employees does Oncopeptides have?
Oncopeptides has 154 employees.
Who are Oncopeptides competitors?
Competitors of Oncopeptides include Candel Therapeutics, PCI Biotech and Propanc Biopharma.
Where is Oncopeptides headquarters?
Oncopeptides headquarters is located at 46 Luntmakargatan, Stockholm.
Where are Oncopeptides offices?
Oncopeptides has offices in Stockholm, Los Altos, Mountain View and Waltham.
How many offices does Oncopeptides have?
Oncopeptides has 5 offices.
Receive alerts for 300+ data fields across thousands of companies